|
|
Brittania House, 7 Trinity Street London, SE1 1DB United Kingdom phone:+44 (0)20 7015 1000 fax:+44 (0)20 7015 1020
|
|
| Symbol |
private |
| Founded |
0 |
| Employees |
|
|
|
| www.arrowt.co.uk
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| New drugs that will not inherit the resistance issues of existing therapies. |
 |
| Management |
| Ken Powell, CEO; Barbara Domayne-Hayman, Commercial Director; Ian Garland, Chief Financial Officer; Stuart Cockerill, Research Director; Sue Grieve, Director of Development and Legal; Dereck Tait, Chief Medical Officer; Dereck Tait, Chief Medical Officer |
| |
|
|
| |
|
| Keywords |
| small molecule drugs, infectious disease,, InfectiousDisease |
|
|
|
| Description |
|
Arrow Therapeutics is focusing on the discovery of new classes of small molecule drugs that will not inherit the resistance issues of existing therapies. |
 |
 |
|
|
|
|
|
|